SA Jagmag, N Tripathi, SD Shukla, S Maiti… - Frontiers in …, 2016 - frontiersin.org
Parkinson's disease is one of the most common neurodegenerative diseases. Animal models have contributed a large part to our understanding and therapeutics developed for …
Methamphetamine (MA) is a extremely addictive psychostimulant drug with a significant abuse potential. Long-term MA exposure can induce neurotoxic effects through oxidative …
S Keshavarzi, S Kermanshahi, L Karami… - Neurotoxicology, 2019 - Elsevier
Background Methamphetamine is a neuro-stimulant with neurodegenerative effects, and ambiguous mechanism of action. Metformin is an antidiabetic agent with neuroprotective …
A Büttner - Neuropathology and applied neurobiology, 2011 - Wiley Online Library
A. Büttner (2011) Neuropathology and Applied Neurobiology37, 118–134 The neuropathology of drug abuse Drug abuse represents a significant health issue. The major …
Methamphetamine (METH) is a highly addictive psychostimulant known for its profound impact on the nervous system. Chronic METH use leads to neurotoxicity characterized by …
M Papageorgiou, A Raza, S Fraser, K Nurgali… - Maturitas, 2019 - Elsevier
The recreational use of methamphetamine (METH, or ice) is a global burden. It pervades and plagues contemporary society; it has been estimated that there are up to 35 million …
PK Thanos, R Kim, F Delis, M Ananth, G Chachati… - PloS one, 2016 - journals.plos.org
Methamphetamine (MA) addiction is a growing epidemic worldwide. Chronic MA use has been shown to lead to neurotoxicity in rodents and humans. Magnetic resonance imaging …
N Szerman, J Martinez-Raga, L Peris… - Addictive Disorders & …, 2013 - journals.lww.com
Objective: Comorbidity of addictive disorders and other psychiatric disorders is very common. The optimal treatment of patients with addiction disorders requires awareness of …